Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.

Pharmaceutical

Esperion Therapeutics

Sheldon Koenig

Ray Mastriani

Michelle Gearhart

Richard Nlemedim

Ben Hong

Priya Batheja

Elena Chekanovsky

Heather Persh

Amy Wilson

Lisa Schafer

Glenn Brame

Ben Halladay

Benjamin O. Looker

Betty Jean Swartz

Eric Warren

JoAnne Micale Foody

Rick Bartram

The Leadership Team at Esperion Therapeutics drives the strategic direction and operational excellence essential for advancing the company's mission to develop innovative LDL-C lowering medicines. Comprised of key executives across finance, medical, commercial, and operational domains, the team collaborates to optimize resources, ensure compliance, and enhance market positioning, all while maintaining a steadfast commitment to addressing global cardiovascular disease.

Leadership Team

Sales and Territory Management

Clinical Research and Development

Leadership Team

About

Team members

Other teams at Esperion Therapeutics

Sales and Territory Management

Clinical Research and Development